This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ricci, M. S. Articles by El-Deiry, W. S. Search for Related Content PubMed PubMed Citation Articles by Ricci, M. S. Articles by El-Deiry, W. S.

Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity

Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, Departments of Medicine, Genetics and Pharmacology, University of Pennsylvania School of Medicine,¹ Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania Philadelphia, Pennsylvania²

Received 28 November 2003/ Returned for modification 16 January 2004/ Accepted 1 July 2004

Tumor necrosis factor alpha (TNF-)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF- family of death receptor ligands and holds great therapeutic potential as a tumor cell-specific cytotoxic agent. Using a panel of established tumor cell lines and normal cells, we found a significant difference between the number of TRAIL-sensitive cells expressing high levels of c-myc and TRAIL-resistant cells expressing low levels of c-myc (P < 0.05, n = 19). We also found a direct linear correlation between c-myc levels and TRAIL sensitivity in TRAIL-sensitive cell lines (r = 0.94, n = 6). Overexpression of c-myc or activation of a myc-estrogen receptor (ER) fusion sensitized TRAIL-resistant cells to TRAIL. Conversely, small interfering RNA (siRNA)-mediated knockdown of c-myc significantly reduced both c-myc expression and TRAIL-induced apoptosis. The gene encoding the inhibitor of caspase activation, FLICE inhibitory protein (FLIP), appears to be a direct target of c-myc-mediated transcriptional repression. Overexpression of c-myc or activation of myc-estrogen receptor (ER) decreased FLIP levels both in cell culture and in mouse models of c-myc-induced tumorigenesis, while knocking down c-myc using siRNA increased FLIP expression. Chromatin immunoprecipitation and luciferase reporter analyses showed that c-myc binds and represses the human FLIP promoter. c-myc expression enhanced TRAIL-induced caspase 8 cleavage and FLIP cleavage at the death-inducing signaling complex. Combined siRNA-mediated knockdown of FLIP and c-myc resensitized cells to TRAIL. Therefore, c-myc down-regulation of FLIP expression provides a universal mechanism to explain the ability of c-myc to sensitize cells to death receptor stimuli. In addition, identification of c-myc as a major determinant of TRAIL sensitivity provides a potentially important screening tool for identification of TRAIL-sensitive tumors.

This article has been cited by other articles:

• Benayoun, B., Baghdiguian, S., Lajmanovich, A., Bartoli, M., Daniele, N., Gicquel, E., Bourg, N., Raynaud, F., Pasquier, M.-A., Suel, L., Lochmuller, H., Lefranc, G., Richard, I. (2008). NF-{kappa}B-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A. FASEB J. 22: 1521-1529 [Abstract] [Full Text]  
• Kim, S.-H., Ricci, M. S., El-Deiry, W. S. (2008). Mcl-1: A Gateway to TRAIL Sensitization. Cancer Res. 68: 2062-2064 [Abstract] [Full Text]  
• Zhang, X., Zhang, L., Yang, H., Huang, X., Otu, H., Libermann, T. A., DeWolf, W. C., Khosravi-Far, R., Olumi, A. F. (2007). c-Fos as a Proapoptotic Agent in TRAIL-Induced Apoptosis in Prostate Cancer Cells. Cancer Res. 67: 9425-9434 [Abstract] [Full Text]  
• Ivanov, V. N., Zhou, H., Hei, T. K. (2007). Sequential Treatment by Ionizing Radiation and Sodium Arsenite Dramatically Accelerates TRAIL-Mediated Apoptosis of Human Melanoma Cells. Cancer Res. 67: 5397-5407 [Abstract] [Full Text]  
• Li, W., Zhang, X., Olumi, A. F. (2007). MG-132 Sensitizes TRAIL-Resistant Prostate Cancer Cells by Activating c-Fos/c-Jun Heterodimers and Repressing c-FLIP(L). Cancer Res. 67: 2247-2255 [Abstract] [Full Text]  
• Roue, G., Perez-Galan, P., Lopez-Guerra, M., Villamor, N., Campo, E., Colomer, D. (2007). Selective Inhibition of I{kappa}B Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing Cellular FLIP Level. J. Immunol. 178: 1923-1930 [Abstract] [Full Text]  
• Kim, S.-H., Nakagawa, H., Navaraj, A., Naomoto, Y., Klein-Szanto, A. J.P., Rustgi, A. K., El-Deiry, W. S. (2006). Tumorigenic Conversion of Primary Human Esophageal Epithelial Cells Using Oncogene Combinations in the Absence of Exogenous Ras. Cancer Res. 66: 10415-10424 [Abstract] [Full Text]  
• Panner, A., Nakamura, J. L., Parsa, A. T., Rodriguez-Viciana, P., Berger, M. S., Stokoe, D., Pieper, R. O. (2006). mTOR-Independent Translational Control of the Extrinsic Cell Death Pathway by RalA. Mol. Cell. Biol. 26: 7345-7357 [Abstract] [Full Text]  
• Finnberg, N., El-Deiry, W. S. (2006). Selective TRAIL-Induced Apoptosis in Dysplastic Neoplasia of the Colon May Lead to New Neoadjuvant or Adjuvant Therapies.. Clin. Cancer Res. 12: 4132-4136 [Full Text]  
• Zhang, X. D., Wu, J. J., Gillespie, S., Borrow, J., Hersey, P. (2006). Human Melanoma Cells Selected for Resistance to Apoptosis by Prolonged Exposure to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Are More Vulnerable to Necrotic Cell Death Induced by Cisplatin. Clin. Cancer Res. 12: 1355-1364 [Abstract] [Full Text]  
• Rottmann, S., Wang, Y., Nasoff, M., Deveraux, Q. L., Quon, K. C. (2005). From the Cover: A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3{beta}/FBW7 loss of function. Proc. Natl. Acad. Sci. USA 102: 15195-15200 [Abstract] [Full Text]  
• Panner, A., James, C. D., Berger, M. S., Pieper, R. O. (2005). mTOR Controls FLIPS Translation and TRAIL Sensitivity in Glioblastoma Multiforme Cells. Mol. Cell. Biol. 25: 8809-8823 [Abstract] [Full Text]  
• Zhang, X.-y., DeSalle, L. M., Patel, J. H., Capobianco, A. J., Yu, D., Thomas-Tikhonenko, A., McMahon, S. B. (2005). Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc. Natl. Acad. Sci. USA 102: 13968-13973 [Abstract] [Full Text]  
• Wang, Y., Quon, K. C., Knee, D. A., Nesterov, A., Kraft, A. S. (2005). RAS, MYC, and Sensitivity to Tumor Necrosis Factor-{alpha}-Related Apoptosis-Inducing Ligand-Induced Apoptosis. Cancer Res. 65: 1615-1617 [Full Text]